Risk Factors for Intracranial Hemorrhage in Acute Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator A Systematic Review and Meta-Analysis of 55 Studies

被引:266
作者
Whiteley, William N. [1 ]
Slot, Karsten Bruins [2 ]
Fernandes, Peter [1 ]
Sandercock, Peter [1 ]
Wardlaw, Joanna [1 ,3 ]
机构
[1] Univ Edinburgh, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Oslo Univ Hosp Ulleval, Oslo, Norway
[3] Scottish Imaging Network, Edinburgh, Midlothian, Scotland
基金
英国医学研究理事会;
关键词
acute stroke; meta-analysis; systematic review; thrombolysis; THROMBOLYTIC THERAPY; INTRAVENOUS THROMBOLYSIS; SAFE IMPLEMENTATION; ALTEPLASE; MANAGEMENT; OUTCOMES; ECASS; TRIAL; SCORE;
D O I
10.1161/STROKEAHA.112.665331
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Recombinant tissue plasminogen activator (rtPA) is an effective treatment for acute ischemic stroke but is associated with an increased risk of intracranial hemorrhage (ICH). We sought to identify the risk factors for ICH with a systematic review of the published literature. Methods-We searched for studies of rtPA-treated stroke patients that reported an association between a variable measured before rtPA infusion and clinically important ICH (parenchymal ICH or ICH associated with clinical deterioration). We calculated associations between baseline variables and ICH with random-effect meta-analyses. Results-We identified 55 studies that measured 43 baseline variables in 65 264 acute ischemic stroke patients. Post-rtPA ICH was associated with higher age (odds ratio, 1.03 per year; 95% confidence interval, 1.01-1.04), higher stroke severity (odds ratio, 1.08 per National Institutes of Health Stroke Scale point; 95% confidence interval, 1.06-1.11), and higher glucose (odds ratio, 1.10 per mmol/L; 95% confidence interval, 1.05-1.14). There was approximately a doubling of the odds of ICH with the presence of atrial fibrillation, congestive heart failure, renal impairment, previous antiplatelet agents, leukoaraiosis, and a visible acute cerebral ischemic lesion on pretreatment brain imaging. Little of the variation in the sizes of the associations among different studies was explained by the source of the cohort, definition of ICH, or degree of adjustment for confounding variables. Conclusions-Individual baseline variables were modestly associated with post-rtPA ICH. Prediction of post-rtPA ICH therefore is likely to be difficult if based on single clinical or imaging factors alone. These observational data do not provide a reliable method for the individualization of treatment according to predicted ICH risk. (Stroke. 2012; 43: 2904-2909.)
引用
收藏
页码:2904 / U235
页数:25
相关论文
共 30 条
[1]   Guidelines for the early management of adults with ischemic stroke - A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups [J].
Adams, Harold P., Jr. ;
del Zoppo, Gregory ;
Alberts, Mark J. ;
Bhatt, Deepak L. ;
Brass, Lawrence ;
Furlan, Anthony ;
Grubb, Robert L. ;
Higashida, Randall T. ;
Jauch, Edward C. ;
Kidwell, Chelsea ;
Lyden, Patrick D. ;
Morgenstern, Lewis B. ;
Qureshi, Adnan I. ;
Rosenwasser, Robert H. ;
Scott, Phillip A. ;
Wijdicks, Eelco F. M. .
STROKE, 2007, 38 (05) :1655-1711
[2]  
[Anonymous], 1995, NEW ENGL J MED, V333, P1581, DOI [10.1056/NEJM199512143332401, DOI 10.1056/NEJM199512143332401]
[3]   Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke [J].
Brown, DL ;
Barsan, WG ;
Lisabeth, LD ;
Gallery, ME ;
Morgenstern, LB .
ANNALS OF EMERGENCY MEDICINE, 2005, 46 (01) :56-60
[4]  
Cucchiara Brett, 2008, J Stroke Cerebrovasc Dis, V17, P331, DOI 10.1016/j.jstrokecerebrovasdis.2008.03.012
[5]   Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy at Stroke Onset [J].
Diedler, Jennifer ;
Ahmed, Niaz ;
Sykora, Marek ;
Uyttenboogaart, Maarten ;
Overgaard, Karsten ;
Luijckx, Gert-Jan ;
Soinne, Lauri ;
Ford, Gary A. ;
Lees, Kennedy R. ;
Wahlgren, Nils ;
Ringleb, Peter .
STROKE, 2010, 41 (02) :288-294
[6]   Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634
[7]   Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK) [J].
Gray, Christopher S. ;
Hildreth, Anthony J. ;
Sandercock, Peter A. ;
O'Connell, Janice E. ;
Johnston, Donna E. ;
Cartlidge, Niall E. F. ;
Bamford, John M. ;
James, Oliver F. ;
Alberti, K. George M. M. .
LANCET NEUROLOGY, 2007, 6 (05) :397-406
[8]   Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].
Hacke, W ;
Kaste, M ;
Fieschi, C ;
von Kummer, R ;
Davalos, A ;
Meier, D ;
Larrue, V ;
Bluhmki, E ;
Davis, S ;
Donnan, G ;
Schneider, D ;
Diez-Tejedor, E ;
Trouillas, P .
LANCET, 1998, 352 (9136) :1245-1251
[9]  
HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017
[10]   Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 - The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee [J].
Hacke, Werner ;
Ringleb, Peter A. ;
Bousser, Marie-Germaine ;
Ford, Gary ;
Bath, Philip ;
Brainin, Michael ;
Caso, Valeria ;
Cervera, Alvaro ;
Chamorro, Angel ;
Cordonnier, Charlotte ;
Csiba, Laszlo ;
Davalos, Antoni ;
Diener, Hans-Christoph ;
Ferro, Jose ;
Hennerici, Michael ;
Kaste, Markku ;
Langhorne, Peter ;
Lees, Kennedy ;
Leys, Didier ;
Lodder, Jan ;
Markus, Hugh S. ;
Mas, Jean-Louis ;
Mattle, Heinrich P. ;
Muir, Keith ;
Norrving, Bo ;
Obach, Victor ;
Paolucci, Stefano ;
Ringelstein, E. Bernd ;
Schellinger, Peter D. ;
Sivenius, Juhani ;
Skvortsova, Veronika ;
Sunnerhagen, Katharina Stibrant ;
Thomassen, Lars ;
Toni, Danilo ;
von Kummer, Ruediger ;
Wahlgren, Nils Gunnar ;
Walker, Marion F. ;
Wardlaw, Joanna .
CEREBROVASCULAR DISEASES, 2008, 25 (05) :457-507